Neurophysiological markers of relapse, remission and long-term recovery processes in MS

Electroencephalogr Clin Neurophysiol Suppl. 1999:50:584-90.

Authors

S J Jones¹, A Brusa

Affiliation

¹ Department of Clinical Neurophysiology, National Hospital for Neurology and Neurosurgery, London, UK. [email protected]

PMID: 10689512

No abstract available

Publication types

Clinical Trial
Controlled Clinical Trial
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Inflammatory Agents / administration & dosage
Biomarkers*
Cross-Sectional Studies
Evoked Potentials, Visual* / drug effects
Evoked Potentials, Visual* / physiology
Follow-Up Studies
Humans
Methylprednisolone / administration & dosage
Multiple Sclerosis, Relapsing-Remitting / diagnosis*
Multiple Sclerosis, Relapsing-Remitting / drug therapy
Multiple Sclerosis, Relapsing-Remitting / physiopathology
Optic Nerve / physiopathology
Optic Neuritis / diagnosis*
Optic Neuritis / drug therapy
Optic Neuritis / physiopathology

Substances

Anti-Inflammatory Agents
Biomarkers
Methylprednisolone